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Introduction
Prolonged mechanical ventilation, aspiration of gastric contents 
into the lungs around the time of death, and immune dysfunc-
tion after brain death all contribute to increased rates of bacterial 
infections in donor lungs (1, 2). Despite the routine use of bron-
choalveolar lavage culture and empiric and pathogen-directed 
antimicrobial therapy, the presence of bacteria in donor lungs 
is associated with increased risk for primary graft dysfunction 
(PGD), the predominant cause of mortality following lung trans-
plantation (3). These high rates of bacterial recovery and the asso-
ciated PGD following transplant are major reasons why donor 
lungs have a utilization rate of only about 15%, which is one of 
the lowest among all solid organs (www.unos.org). The low uti-
lization of donor lungs accounts for the high mortality and long 
wait times observed in patients requiring lung transplantation. 
How bacteria in the donor lungs predispose to the pathogenesis 
of PGD and why antimicrobial therapy is unable to prevent lung 
allograft injury remains unclear.
Host neutrophils recruited to the lung allograft mediate lung 
ischemia/reperfusion injury leading to PGD, the most import-
ant risk factor for early and chronic allograft failure, but are also 
necessary for the clearance of bacterial and fungal pathogens 
(4–13). Since neutrophil depletion is unlikely to be tolerated in 
immunosuppressed lung transplant patients, it is critical to delin-
eate mechanisms leading to neutrophil recruitment immediately 
after transplant. The severity of neutrophil recruitment and the 
resulting PGD varies dramatically among lung transplant recipi-
ents. Because broad-spectrum antibiotics targeting most Gram- 
negative organisms are routinely administered to both the donor 
and recipient before transplantation, the role of bacteria in the 
donor lung in driving this heterogeneity has been overlooked.
Surprisingly, we detected lipopolysaccharide (LPS), also 
referred to as endotoxin, in human donor lungs with bacterial 
pathogens before transplant, despite antibiotic therapy. LPS is a 
prototypical pathogen-associated molecular pattern (PAMP) in 
the outer cytoplasmic membrane of Gram-negative bacteria that 
signals through TLR4 receptors to induce neutrophil influx into 
the alveolar space (4, 14). We recently discovered that donor origin 
pulmonary intravascular nonclassical monocytes (NCMs) trigger 
neutrophil recruitment following lung transplantation through the 
production of neutrophil chemoattractant CXCL2 (11, 13, 15). The 
donor NCMs also recruit spleen-derived CCR2+ classical mono-
Despite the widespread use of antibiotics, bacterial pneumonias in donors strongly predispose to the fatal syndrome of 
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Results
Endotoxin persists in donor lung despite pathogen clearance, and 
predisposes to PGD. Recruitment of host neutrophils to the lung 
allograft following lung transplantation mediates lung ischemia/
reperfusion injury (10). To determine whether bacterial split prod-
ucts in the donor lung could exacerbate neutrophil influx after 
transplant, we analyzed human donor lungs that were positive for 
Gram-negative bacteria before transplant but treated with anti-
microbials. These human donor lungs had normal P/F ratio in 
the donor before transplant and no pulmonary infiltrates on chest 
radiograph or computed tomography. Successful treatment of 
the infection was evident by negative microbial cultures of bron-
choalveolar fluid (BALF) collected at the time of transplantation. 
However, as shown in Figure 1A, the BALF of successfully treated 
human donor lungs obtained at transplant revealed residual endo-
toxin that persisted following transplantation. Intriguingly, fol-
lowing transplantation, these endotoxin-containing donor lungs 
showed physiological markers of injury, including significantly 
higher neutrophil infiltration as well as reduced P/F ratio after 
transplant, compared with those without endotoxin (Figure 1, B 
and C), although there was no significant difference in the neutro-
phil count and P/F ratio between the 2 groups in the donor before 
lung procurement (Figure 1, B and C). We replicated these obser-
vations in a murine model of lung transplantation by administer-
ing intratracheal (i.t.) PBS control or a low dose of LPS from 3 dif-
ferent bacteria (0.5 μg/g BW E. coli, 0.2 μg/g BW P. aeruginosa or 
0.2 μg/g BW K. pneumoniae) to donor mice before transplantation 
into allogeneic murine recipients. The low dose was insufficient to 
cause neutrophil infiltration or injury in the native lungs. However, 
the grafts containing LPS experienced severe PGD at 24 hours, 
which was associated with an increase in chemokines in the BALF 
(Supplemental Figure 1; supplemental material available online 
with this article; https://doi.org/10.1172/JCI135838DS1), includ-
cytes (CMs) to the allograft, which contribute to neutrophil extrav-
asation, worsening lung injury (12). Thus, both donor-derived 
NCMs and recipient CMs play complementary roles in neutrophil 
recruitment and extravasation to initiate lung transplant ischemia/
reperfusion injury. These mechanisms differ from observations 
in naive mice treated with LPS in which tissue-resident alveolar 
macrophages (TRAMs), or other cell populations in the lung, may 
be necessary for neutrophil recruitment (16–19). We therefore 
hypothesized that LPS from the different bacterial pathogens and 
perhaps other PAMPs, persisting after successful antimicrobial 
therapy, contribute to excessive neutrophil recruitment after lung 
transplantation by augmenting signaling through NCMs or CMs, 
and/or activated parallel pathways through TRAMs.
We found that endotoxin can persist in human donor lungs 
despite pathogen clearance and is associated with increased 
neutrophil infiltration and PGD after lung transplantation. 
Pharmacologic and genetic depletion of donor NCMs attenuat-
ed neutrophil recruitment following transplant of naive donor 
lungs (12, 13), but did not abrogate neutrophil recruitment and 
PGD in donor lungs containing endotoxin. In addition, expo-
sure of donor TRAMs to ischemia/reperfusion primed them 
to release CXCL2 in response to endotoxin through a TLR4/
MyD88 pathway, obviating the requirement for donor NCMs in 
neutrophil recruitment to the allograft. Donor lungs produced 
reactive oxygen species (ROS), beginning in the warm-ischemia 
phase, which led to both an increase in TLR4 transcription and 
its translocation to the cell plasma membrane. Accordingly, 
ROS scavengers, blockade of TLR4, or TLR4 coreceptor CD14 
resulted in amelioration of PGD when endotoxin was present in 
the donor lungs. Our results suggest that a multipronged strat-
egy that targets both TRAMs and NCMs within the donor lung 
can reduce the severity of PGD in donors with a history of bacte-
rial pneumonia or colonization.
Figure 1. Persistence of endotoxin in human and murine donor lungs is associated with neutrophil influx and PGD following transplantation. (A) 
Human donor lungs with microbial cultures positive for Gram-negative bacteria were treated with antimicrobials, resulting in clearance of the pathogen 
at the time of transplantation. To test for persistence of endotoxin, BALF serially obtained from the same patient was analyzed (n = 9). (B) Human donor 
lungs from endotoxin-negative and endotoxin-positive lungs were analyzed for tissue neutrophil infiltration before reperfusion and 30 minutes after 
reperfusion using intraoperative lung biopsy of the inferior lingular segment (n = 10). (C) To determine the function of the lung allograft, we obtained 
blood directly from the pulmonary vein confluence immediately proximal to the site of venous anastomosis and analyzed partial pressure of oxygen (PaO2 
mmHg) before and after reperfusion. The PaO2 to fractional inspired oxygen (FiO2) ratio (P/F ratio) was then calculated for lungs negative and positive for 
endotoxin (n = 12). (D) Donor mice were administered a low dose of LPS i.t. (E. coli [0.5 μg/g BW], P. aeruginosa [0.2 μg/g BW], and K. pneumoniae [0.2 
μg/g BW]), insufficient to cause injury in native lung, and then lungs were transplanted into allogeneic recipients. The neutrophil infiltration was then 
analyzed following transplant (n = 3–6). Graphs show mean ± SD. Graphs were analyzed by unpaired t test. *P < 0.05; **P < 0.01; ****P < 0.0001.
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BW) i.t. LPS administration there was a robust neutrophil influx 
(Supplemental Figure 3A) in native lungs with more than 80% of 
neutrophil extravasated into the alveolar space (Supplemental Fig-
ure 3B). This was accompanied by pulmonary edema and histo-
logic signs of injury (Supplemental Figure 3, C and D) (27, 28). We 
then performed RNA-Seq analysis of flow-sorted TRAMs isolated 
from BALF in patients with severe pneumonia resulting in respi-
ratory failure in our medical intensive care unit (16). Specifically, 
we compared alveolar macrophage transcriptomes from patients 
with confirmed pneumonia secondary to Pseudomonas aeruginosa  
(based on quantitative culture of the same BALF sample) to tran-
scriptomes of patients with negative quantitative culture and 
found that differentially expressed genes were associated with 
gene ontology (GO) processes involved in immune activation (Fig-
ure 2, A and B). We found that those genes associated with the GO 
processes in human subjects were also differentially expressed in 
the TRAMs of humanized Rag–/– IL2g–/– mice with transgenes for 
human GM-CSF and IL-3 (MISTRG mice) infected with Pseudomo-
nas (Figure 2C). Furthermore, compared with those without pneu-
monia, TRAMs from patients with Pseudomonas pneumonia and 
MISTRG mice infected with P. aeruginosa demonstrated a signif-
icant increase in the expression of the primary neutrophil chemo-
kine, CXCL2 (Figure 2D), which we have shown to be pivotal in 
neutrophil chemotaxis to the reperfused lung allograft (11, 13, 15).
To further investigate whether TRAMs were responsible for 
CXCL2 production in response to LPS in TLR4-dependent manner, 
ing CXCL2, a potent neutrophil chemoattractant (13, 20), as well as 
profound neutrophil influx (Figure 1D). These data suggested that 
low levels of endotoxin may not cause clinically significant lung 
injury; however, following ischemia/reperfusion, the susceptibility 
of lung allografts to residual endotoxin increases substantially. 
Finally, recent studies have suggested that the donor microbi-
ome may play a role in the development of lung allograft rejection 
(21–24). Since the role of the donor lung microbiome in the patho-
genesis of PGD is uncertain, we analyzed the BALF from human 
donor lungs by 16S PCR high-throughput screening, as previously 
described (25, 26). BAL samples were distinct from rectal samples 
(R = 0.977, P = 0.002), and no microbial clustering within BAL sam-
ples was apparent. PGD sample (patient 9) was not dissimilar from 
non-PGD samples (patients 1–7, 8, 10) (R = –0.279, P = 0.625). There 
was also no variation in the donor lung microbiome with regard to 
endotoxin-containing organisms and this lack of variation is, there-
fore, unlikely to explain our results (Supplemental Figure 2).
CXCL2 secreted from TRAMs contributes to neutrophil recruit-
ment and lung injury following bacterial infection or LPS admin-
istration. To determine the mechanisms by which endotoxin in 
donor lungs accentuates PGD, we first studied the mechanism of 
endotoxin-induced lung injury in the native mouse lung. Given 
that LPS from all 3 bacterial species induced PGD and neutrophil 
influx, for subsequent studies we used LPS from E. coli since it 
has been used most commonly in published literature. Consistent 
with prior reports, we found that 24 hours after high dose (2 μg/g 
Figure 2. TRAMs upregulate CXCL2 in response  
to endotoxin and pseudomonas. Transcriptomic 
profiling of human TRAMs during Gram-nega-
tive bacterial pneumonia revealed upregulation 
of CXCL2, a known neutrophil chemoattractant. 
TRAMs were identified as CD15–HLA–DR+CD169+ 
CD206++, and flow sorted for RNA isolation,  
library preparation, and sequencing (culture- 
negative, n = 4; P. aeruginosa–positive, n = 6). (A) 
Heatmap of top 1000 most significantly differen-
tially expressed genes ranked by FDR q value. Both 
samples and genes are grouped by hierarchical 
clustering. (B) Functional enrichment analysis with 
GO biological processes was performed with GOrilla 
with the top 1000 genes upregulated in P. aeru-
ginosa–positive samples for all clusters. In total, 
443 significantly upregulated genes were used 
to identify the top 5 biological processes (–log10 
[P value]). (C) Heatmap of pathway genes (750 
genes) based on the top GO processes identified 
in B (GO:0002376,GO:0019221, GO:0002237,GO:00
06954,GO:0006950). Hierarchical clustering shows 
the expression of these genes in naive, low, and 
high virulence samples for MISTRG mice. Selective 
genes are highlighted (n = 3–4). (D) Normalized 
CPM counts of CXCL2 in both human and MISTRG 
mouse following infection with P. aeruginosa (n = 
3–6). Graph show mean ± SD and was analyzed by 
unpaired t test.**P < 0.01.
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CCR2 antibody (Supplemental Figure 6, A–C), NCMs using intra-
venously administered Clo-lip (Supplemental Figure 6, D–F), or 
simultaneous depletion of monocytes, peribronchial interstitial 
macrophages, and lung CD11b+ dendritic cells using CD11b-DTR 
system, had no effect on neutrophil trafficking in response to i.t. 
LPS (Supplemental Figure 6, G and H). Taken together, these data 
demonstrate that TRAMs are responsible for neutrophil influx in 
response to LPS through the production of CXCL2.
Donor TRAMs exacerbate PGD in donor lung containing endotoxin 
through the production of CXCL2. We have recently shown that 
donor origin pulmonary intravascular NCMs recruit neutrophils 
following transplant and contribute to the pathogenesis of PGD in 
a mouse model of lung transplantation (12, 13). As bacterial infec-
tions are common in human donor lungs, we investigated whether 
NCMs, TRAMs, or both would mediate neutrophil recruitment in 
donor lungs exposed to LPS. Accordingly, we treated donors with 
a low dose of LPS (0.5 μg/g BW), insufficient to cause donor lung 
injury, and found that while LPS-free donor lungs from mice lack-
ing NCMs (Nr4a1–/–) did not develop neutrophil recruitment and 
PGD following lung transplantation (13), in contrast, donor lungs 
from low-dose LPS-treated Nr4a1–/– mice did (Figure 4, A and B). 
Similarly, pharmacological depletion of donor NCMs using i.v. 
Clo-lip prevented neutrophil recruitment following murine lung 
transplant of LPS-free (13), but not of LPS-containing, donor lungs 
(Figure 4, A and B), suggesting that neutrophil recruitment associ-
we analyzed expression of TLR4 in previously published single- 
cell RNA-seq data sets generated from nondiseased human lungs 
(29–31) (Supplemental Figure 4). Expression of TLR4 was largely 
restricted to FABP4-positive TRAMs, although some endothe-
lial cells and monocytes also demonstrated expression of TLR4. 
Given that endothelial cells face the vasculature and monocytes 
in human lungs are largely retained in the blood vessels (13, 32), 
TRAMs are likely to be the predominant secretors of CXCL2 in 
response to TLR4 stimulation by LPS present in the alveolar space. 
Nevertheless, to confirm that TRAMs drive neutrophil recruit-
ment in response to LPS, we administered clodronate-loaded 
liposomes intratracheally to selectively deplete TRAMs in WT 
mice (Supplemental Figure 5). Depletion of TRAMs before LPS 
challenge in WT mice resulted in a significant decrease in CXCL2 
levels in BALF (Figure 3A) along with a significant reduction in 
neutrophil infiltration in lung tissue, determined by flow cytom-
etry (Figure 3B) and 2-photon microscopy (Figure 3, C and D; and 
Supplemental Videos 1 and 2). Next, to determine whether CXCL2 
signaling was necessary for neutrophil recruitment in response to 
LPS, we treated mice with anti-CXCL2 antibodies (13). Neutraliza-
tion of CXCL2 resulted in a significant attenuation of neutrophil 
recruitment to the injured lungs, 24 hours after LPS administra-
tion (Figure 3E). Similarly, mice deficient in the CXCL2 receptor 
(Cxcr2–/–) did not develop neutrophil influx in response to i.t. LPS 
(Figure 3F). Moreover, depletion of circulating CMs using anti-
Figure 3. Influx of neutrophils into LPS-treated lung is abrogated by selective depletion of TRAMs. (A) CXCL2 chemokine levels in BALF of LPS-treated 
mice injected with PBS-lip or Clo-lip i.t. (n  = 5–6). (B) Quantification of neutrophil infiltration into lungs in TRAM-depleted compared with PBS-lip control 
mice 24 hours after LPS administration (n = 6–11). Neutrophils were gated as live CD45+Ly6G+CD11b+CD24+SSChi cells. (C) Representative intravital 2-photon 
microscopy images of control PBS-lip– or Clo-lip–treated lungs 4 hours after LPS administration in B6 LysM-GFP mice (also refer to Supplemental Videos 
1 and 2). Q-dots (655-nm nontargeted) were injected 5 minutes before imaging to label the vessels red (n = 3). (D) Quantification of total GFP+ neutrophils 
from C (n = 3). (E) Quantification of neutrophil infiltration into lungs in LPS-treated mice previously injected with IgG or an antibody against CXCL2 (n = 3–4). 
(F) Quantification of neutrophil infiltration into lungs in LPS-treated mice in WT (WT) compared with Cxcr2–/– (Cxcr2.KO) mice (n = 3–6). Scale bar: 30 μm. All 
graphs show mean ± SD. Graphs were analyzed by unpaired t test. *P < 0.05; **P < 0.01; ***P < 0.001.
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containing donor lungs, we treated recipients with an anti-CXCL2 
antibody immediately after transplantation or used Cxcr2–/– mice 
as transplant recipients. In both cases, neutrophil recruitment 
after transplantation of the endotoxin-containing donor lung was 
attenuated (Figure 4, A and B). Collectively, these results show that 
ischemia/reperfusion-primed TRAMs can recruit neutrophils in 
lung allografts containing low levels of endotoxin through CXCL2 
release, obviating the requirement for NCMs.
TRAM-mediated neutrophil recruitment in response to endotoxin 
is dependent on TLR4-MyD88 signaling. The pattern recognition 
receptor for LPS is toll-receptor 4 (TLR4), which interacts with the 
intracellular adaptor protein MyD88 to enable signal transduction 
(33). In order to test whether the TLR4-MyD88 signaling pathway 
was responsible for the LPS priming of TRAMs before lung trans-
ated with LPS in donor lungs is NCM independent. On the other 
hand, depletion of TRAMs in LPS-treated Nr4a1–/– donor lungs 
before transplant using i.t. Clo-lip or depletion of both TRAMs 
and NCMs by i.t. plus i.v. Clo-lip in WT donor lungs attenuated the 
LPS-induced neutrophil infiltration (Figure 4, A and B).
We have reported that Nr4a1–/– donor lungs have reduced 
CXCL2 levels following transplant when compared with WT donor 
lungs (13). However, administration of low-dose LPS to Nr4a1–/– 
donor lungs before transplantation resulted in increased CXCL2 
levels (Figure 4C). We also found increased CXCL2 mRNA expres-
sion in TRAMs isolated from human donor lungs positive for endo-
toxin compared with those negative for endotoxin following trans-
plantation reperfusion (Figure 4D). To determine whether CXCL2 
was necessary for the recruitment of neutrophils in endotoxin- 
Figure 4. Influx of recipient neutrophils into the allograft containing LPS is abrogated by depletion of donor TRAMs and is CXCL2 dependent. (A) 
Diagram depicting experiment shown in B. WT C57BL/6 mice received BALB/c allogeneic donor lungs containing low-dose LPS (0.5 μg/g BW) injected i.t., 
insufficient to cause native lung injury. To deplete NCMs, donors were treated with i.v. Clo-lip before i.t. LPS. To deplete both donor monocytes and donor 
TRAMs, we treated the donors with i.v. Clo-lip and i.t. Clo-lip, respectively, before i.t. LPS. Next, we used Nr4a1–/– donor lungs containing low-dose LPS and 
transplanted them into WT recipients after depletion of TRAMs using i.t. Clo-lip, or using PBS-lip as control. Last, to determine whether CXCL2 secretion 
by donor TRAMs led to neutrophil recruitment, we treated recipients of Nr4a1–/– donor lungs containing low-dose LPS with anti-CXCL2 antibodies at the 
time of transplantation. Additionally, we transplanted Nr4a1–/– donor lungs containing low-dose LPS into Cxcr2–/– recipients and determined neutrophil 
infiltration at 24 hours.(B) Quantification of neutrophil infiltration into lungs after these treatments was performed using flow cytometry (n = 4–5). (C) 
CXCL2 chemokine levels in BALF of recipient mice after receiving low-dose LPS-treated Nr4a1–/– donor lungs compared with PBS-treated Nr4a1–/– donor 
lungs (n = 5). (D) TRAMs were isolated from endotoxin-negative and endotoxin-positive human donor lungs at 120 minutes after reperfusion and analyzed 
for CXCL2 transcription (n = 4). All graphs show mean ± SD. Graph in B was analyzed by 1-way ANOVA followed by Tukey’s post hoc test. Graphs in C and D 
were analyzed by unpaired t test. ***P < 0.01; ****P < 0.0001. CT, control.
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plantation, we crossed Cd11cCre transgenic mice with Myd88fl/fl 
(Myd88Δ) mice to generate Cd11cCreMyd88Δ mice, which lack MyD88 
expression specifically in TRAMs and DCs. Cd11cCreMyd88Δ mice 
had similar numbers of TRAMs compared with WT mice (Figure 
5A); however, they showed an attenuated neutrophil infiltration 
to the lungs in response to LPS (Figure 5B). We then performed a 
rescue experiment in which we treated the Cd11cCre-Myd88Δ mice 
with i.t. liposomal clodronate to deplete TRAMs lacking MyD88 
expression, and then adoptively transferred TRAMs from WT or 
Tlr4–/– mice. As shown in Figure 5, C and D, reconstitution with 
WT TRAMs restored neutrophil infiltration, whereas reconstitu-
tion with TRAMs lacking TLR4 expression showed no difference in 
neutrophil recruitment compared with Cd11cCreMyd88Δ mice. This 
indicated that the neutrophil recruitment by TRAMs in response to 
LPS is dependent on TLR4-MyD88 signaling.
Lung transplant ischemia/reperfusion activates TRAMs to 
increase CXCL2 production in response to endotoxin via TLR4 regu-
lation. Human TRAMs isolated from donor lungs containing endo-
toxin produced increased amounts of CXCL2 following reperfu-
sion compared with TRAMs isolated from endotoxin-free human 
lungs (Figure 6A). Moreover, ischemia/reperfusion-primed 
human donor TRAMs produced more CXCL2 in vitro in response 
to the same amount of endotoxin compared with their native state 
(Figure 6B and Supplemental Figure 7). Therefore, we explored 
the role of ischemia/reperfusion in priming TRAMs to endotoxin 
using murine models. Similar to humans, TRAMs isolated from 
murine donor lungs after ischemia produced significantly more 
CXCL2 upon stimulation with LPS (Figure 6, C and D). We next 
performed RNA-Seq analysis of donor TRAMs experiencing 
ischemia/reperfusion injury (13, 34), which revealed upregulation 
of TLR4 and its coreceptor CD14 (Figure 7A). We validated these 
findings by performing quantitative real-time PCR of TRAMs 
isolated from murine donor lungs before and after ischemia 
(Figure 7B). To understand TLR4 regulation during ischemia/
reperfusion injury, we performed a time course after ischemia, 
analyzing both Tlr4 mRNA levels and protein expression at the 
plasma membrane in TRAMs. We found that Tlr4 mRNA levels 
started increasing 4 hours after ischemia, reaching significance 
at 24 hours (Figure 7C). Using flow cytometry, we determined 
that TLR4 protein expression at the plasma membrane reached 
statistical significance at 4 hours after ischemia, keeping a con-
stant expression at 24 hours (Figure 7D). Moreover, immunocy-
tochemistry (ICC) performed in donor TRAMs isolated at serial 
time points following transplantation showed that TLR4 increas-
ingly accumulated toward the cell periphery following trans-
plantation (Figure 7E, Supplemental Figure 8 and Supplemental 
Figure 9). These results suggest that ischemia/reperfusion injury 
induces TLR4 translocation to the plasma membrane at earlier 
time points (35), followed by increased de novo synthesis at 
later time points. Finally, to determine whether TLR4 signaling is 
necessary for LPS-induced activation of donor lung TRAMs, we 
administered LPS in the presence of TLR4 antagonist (TAK-242) 
or CD14/TLR4 antagonist (IAXO-101) and then transplanted 
these lungs into WT recipients. We found that anti-TLR4 treat-
Figure 5. TLR4-MyD88 signaling 
directs TRAM-mediated neutrophil 
recruitment. (A) Flow cytometry 
quantification of TRAMs in WT and 
Cd11cCreMyd88Δ mice (n = 5–7). TRAMs 
were gated as live CD45+Ly6G–NK1.1–
SiglecF+CD64+ cells. (B) Flow cytom-
etry quantification of neutrophil 
(live CD45+Ly6G+CD11b+CD24+SSChi 
cells) infiltration into lungs after i.t. 
LPS (2 μg/g BW) in Cd11cCreMyd88Δ 
compared with control WT mice (n 
= 6). (C) Diagram depicting TRAM 
reconstitution experiment shown in 
D. (D) Flow cytometry quantification 
of neutrophil infiltration into lungs 
determined as in B after i.t. LPS (2 
μg/g BW) in Cd11cCreMyd88Δ mice 
reconstituted with WT (WT TRAM) 
or Tlr4–/– TRAMs (Tlr4.KO TRAM) 
compared with Cd11cCreMyd88Δ mice 
(n = 5–6). All graphs show mean ± SD. 
(A and B) Graphs were analyzed 
by unpaired t test. (C) Graph was 
analyzed by 1-way ANOVA followed 
by Tukey’s post hoc test. *P = 0.05; 
****P < 0.0001.
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ment suppressed the neutrophil influx after transplant associated 
with LPS (Figure 7F).
ROS released during warm ischemia and following reperfusion 
increased the transcription of TLR4 and its translocation to the cell 
membrane in TRAMs. ROS generated in the mitochondria have 
been implicated in signaling pathways activated after ischemia/
reperfusion injury (36, 37). To explore whether ROS are neces-
sary for the increased transcription of TLR4 in donor TRAMs, we 
analyzed ROS generation in donor human lung tissue and TLR4 
mRNA expression in TRAMs at 5 consecutive time points during 
ischemia/reperfusion. Donor tissue was harvested as follows: (a) 
in situ native lung: biopsies obtained after opening donor’s chest 
cavity and before procurement; (b) end of cold ischemia: biopsies 
obtained after the donor lung was removed from cold-storage 
but before initiation of implantation; (c) end of warm ischemia: 
biopsies obtained from the donor lung that 
sustained warm ischemia during implanta-
tion but immediately before reperfusion; (d) 
30 minutes after reperfusion; and (e) 120 
minutes after reperfusion. We found that 
ROS increased during the warm-ischemia 
phase and continued to increase at 30 and 
120 minutes after reperfusion (Figure 8A). 
Intriguingly, TLR4 transcription in human 
donor TRAMs did not increase until 30 
minutes after reperfusion but continued to 
increase at the 120-minute time point (Fig-
ure 8A). It was clinically infeasible to eval-
uate TRAMs from the donor lung tissue site 
at longer time points since the chest of the 
recipient is closed at the conclusion of the 
surgical procedure. Accordingly, we per-
formed experiments using exogenous ROS to 
replicate these findings. We cultured murine 
TRAMs in the presence of 100 μM hydrogen 
peroxide, as previously described (35). At 1 
hour, we did not observe any change in Tlr4 
transcription, but its translocation to the cell 
membrane increased significantly (Supple-
mental Figure 10, A and B). Unfortunately, 
we could not evaluate the effects of hydro-
gen peroxide on TRAMs in vitro beyond 1 
hour, as we observed progressive cell death 
at longer time points (Supplemental Figure 
10C). Nevertheless, using the murine model 
of lung transplantation, we could confirm a 
role for mitochondrial ROS by using the gen-
eral ROS scavenger N-acetylcysteine (NAC) 
(38), and the mitochondrial ROS scaven-
gers Mito-Tempo (MT) (39) and dimethyl 
malonate (DM) (40) to abrogate the isch-
emia/reperfusion-induced increase in Tlr4 
transcription and expression at the plasma 
membrane. Indeed, donor TRAMs did not 
develop an increase in Tlr4 transcription or 
TLR4 protein translocation to the plasma 
membrane following murine lung transplan-
tation when treated with NAC, MT, or DM as demonstrated by 
both qualitative and quantitative measures (Figure 8, B–D). More-
over, NAC treatment prevented neutrophil recruitment and devel-
opment of PGD in endotoxin-containing Nr4a1–/– donor lungs 
(Figure 8, E and F).
Discussion
Despite the increasing numbers of lung transplants worldwide, 
there is a significant gap between the demand and availability of 
lungs for transplants (41). Many potential donor lungs with ade-
quately treated donor pneumonias are turned down at the time of 
evaluation because of concerns for the development of PGD fol-
lowing transplantation (42–44). While neutrophil recruitment into 
the transplanted lung allograft is essential for the development 
of PGD, a lack of insight into mechanisms that drive neutrophils 
Figure 6. Ischemia/reperfusion-primed TRAMs have augmented response to endotoxin. (A) 
Relative CXCL2 mRNA levels of human TRAMs from endotoxin-negative and endotoxin-positive 
patients before and after reperfusion (n = 6). (B) Fresh TRAMs from endotoxin-negative human 
donor lungs were isolated before transplantation or 120 minutes after reperfusion and then stim-
ulated with endotoxin in vitro (0.01 μg/mL LPS) (n = 10). (C) Diagram depicting the experiments 
illustrated in D, where TRAMs harvested before and after ischemia were challenged with LPS in 
vitro. (D) CXCL2 chemokine levels in the supernatant of murine TRAMs harvested before and after 
ischemia and challenged in vitro with LPS (0.01 μg/mL) for 4 hours (n = 3–4). (A–C) Graphs were 
analyzed by unpaired t test. *P < 0.05; **P < 0.01; ****P < 0.0001.
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on TRAMs, potentially creating a feed-forward loop to sustain neu-
trophil recruitment. The importance of LPS/TLR4/MyD88 signal-
ing in TRAMs was confirmed by using genetic and pharmacologic 
inhibitors combined with cell-specific depletion and reconstitution 
studies. In marked contrast to the requirement of NCMs for neu-
trophil recruitment into allografts from naive donors (13), TRAMs 
in the donor lung were indispensable and NCMs were dispensable 
for neutrophil recruitment in LPS-contaminated donors. These 
findings show that the exposure history in the donor can reshape 
neutrophil responses during lung transplantation.
Release of ROS during ischemia/reperfusion injury contrib-
utes to the pathogenesis of organ dysfunction (37). We analyzed 
human donor lungs longitudinally to evaluate for the production 
of ROS. We found that ROS started to increase during the warm- 
ischemia phase and continue to do so following reperfusion, but the 
increase in TLR4 transcription was not observed until 30 minutes 
into the allograft has precluded therapies targeted to the donor or 
recipient that might attenuate their recruitment and the attendant 
lung injury. We found that human donor lungs successfully treated 
for bacterial pneumonia had residual endotoxin despite the clear-
ance of bacterial pathogen. In a mouse lung transplant model, lev-
els of endotoxin insufficient to induce detectable injury in donor 
lungs was associated with increased neutrophil recruitment as 
well as physiological markers of allograft injury. This is consistent 
with the observed association between historic pneumonia in the 
donor lung and PGD (44).
We used a mouse model of lung transplant to elucidate the 
mechanisms by which a low level of LPS in the donor lung induces 
neutrophil recruitment into the allograft. We found that endotoxin 
in the donor lung primes donor TRAMs to release CXCL2 after lung 
transplantation, leading to neutrophil recruitment. We also found 
that ischemia reperfusion injury upregulates both TLR4 and CD14 
Figure 7. TRAMs exposed to ischemia/reperfusion have increased TLR4 transcription and translocation to the plasma membrane. (A) Heatmap of 
selected TLR4 pathway genes expressed in murine donor TRAMs exposed to ischemia/reperfusion (n = 3–5). (B) Tlr4 and Cd14 mRNA expression in TRAMs 
harvested from BALF before and after ischemia at 24 hours was assessed by qPCR (n = 3). (C) Expression level of Tlr4 mRNA in TRAMs harvested from 
BALF before ischemia and 1 hour, 4 hours, and 24 hours after ischemia, assessed by qPCR (n = 3–5). (D) Protein expression of TLR4 at the plasma mem-
brane in TRAMs harvested as in C, assessed by flow cytometry (n = 3–5). (E) Immunocytochemistry for TLR4 of TRAMs harvested as described in C. (F) WT 
C57BL/6 donor mice were treated with low-dose i.t. LPS (0.5 μg/g BW) alone or in combination with TLR4 antagonist (TAK-242; 1 μg/g BW, i.v.) or IAXO-101 
(3 μg/g BW, i.t.) and neutrophil recruitment was assessed 24 hours after ischemia. Neutrophils were gated as live CD45+Ly6G+CD11b+CD24+SSChi cells (n = 
4–5). (B) Graph was analyzed by unpaired t test. (C, D, and F) Graphs were analyzed by 1-way ANOVA followed by Tukey’s post hoc test. *P < 0.05; **P < 
0.01; ***P < 0.001; ****P < 0.0001. Scale bar: 10 μm. Arrow points to TLR4 at the plasma membrane.
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from LPS treated donors and NCMs responded to lung transplant 
mediated ischemia reperfusion injury by releasing CXCL2, also 
known as MIP-2 (13, 48). While other cytokines and chemokines 
play a role in the initiation and propagation of the inflammatory 
response, the focus of our work was on neutrophil recruitment. 
Our focus on CXCL2 was justified based on our prior publication 
(13) which revealed a nonredundant role of CXCL2 in neutrophil 
recruitment to the allograft following lung transplantation and 
supported by our analysis of several other cytokines in LPS con-
taining donor lungs (Supplemental Figure 1). Causal evidence 
comes from the murine transplant model where genetic or phar-
macological neutralization of CXCL2 in the LPS primed donor 
lung reduced neutrophil recruitment. Furthermore, we found that 
inhibition of mitochondrial ROS, which have been implicated in 
signaling pathways induced by ischemia reperfusion injury (36, 
37), attenuated CXCL2 mediated neutrophil recruitment after 
after reperfusion (45). As warm ischemia lasts 45 to 60 minutes, we 
concluded that the increase in TLR4 transcription lags generation 
of ROS by 1 to 2 hours. We confirmed these findings in the murine 
lung transplant model where the expression of TLR4 increased 
after transplant and were inhibited using the general ROS scav-
enger N-acetylcysteine (NAC) (46) as well as the mitochondrial 
ROS scavengers Mito-Tempo (MT) (39) and dimethyl malonate 
(DM) (40). Further work is needed to determine the mechanisms 
by which ROS augment Tlr4 and Cd14 transcription and whether 
ischemia reperfusion driven ROS also augment TLR4 transloca-
tion to the plasma membrane via Src-dependent signaling through 
generation of ceramide as has been described (35, 47).
Our findings provide a mechanistic explanation for the marked 
and unpredictable heterogeneity between transplant recipients in 
the incidence and severity of PGD with implications for therapy. 
Specifically, we found that both primed alveolar macrophages 
Figure 8. ROS produced during ischemia reperfusion are responsible for TLR4 upregulation. (A) Human donor lungs being used for clinical transplan-
tation were serially biopsied during the different phases of ischemia/reperfusion and development of ROS, and TLR4 transcription of flow-sorted donor 
TRAMs was determined. (B) WT BALB/c mice were transplanted with WT C57BL/6 donor lungs. In order to test the effect of ROS on TLR4 expression in 
TRAMs, we treated donors and recipient with NAC (100 mg/kg BW), MT (5 mg/kg BW, i.p.), or DM (10 mg/kg BW, i.v.), before and after reperfusion. Tlr4 
mRNA levels were assessed 24 hours after ischemia by qPCR in TRAMs harvested from BALF before and after transplantation (n = 3–5). (C) Protein expres-
sion of TLR4 at the plasma membrane in TRAMs harvested as in B, assessed by flow cytometry (n = 4). (D) Immunocytochemistry for TLR4 of TRAMs 
harvested as described in B. Nr4a1–/– donor lungs, which do not develop PGD, were administered low-dose LPS and transplanted into WT recipients with or 
without NAC treatment. (E) Neutrophil infiltration was determined using flow cytometry and (F) lung function was determined using blood gases and P/F 
ratio. (B, C) Graphs were analyzed by 1-way ANOVA followed by Tukey’s post hoc test. (E, F) Graphs were analyzed by unpaired t test. *P < 0.05; ## and **P 
< 0.01; ### and ***P < 0.001; ****P < 0.0001. (A) *ROS; #TLR4 transcription. Scale bar: 10 μm. Arrow points to TLR4 at the plasma membrane.
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necessary for the production of CXCL2, it has been shown that 
alveolar epithelial cells can also produce CXCL2 in response to 
pathogens (49). Additionally, we focused on neutrophil recruit-
ment mediated by CXCL2 as it is the earliest event in the devel-
opment of PGD. However, our current and previously published 
data suggest that the development of PGD involves several cell 
populations including NCMs, neutrophils, alveolar macrophages, 
and CMs. The complex signaling pathways leading to their orches-
trated sequential recruitment and activation are incompletely 
understood. While we show a clear role for retained endotoxin 
from different bacterial pathogens in neutrophil recruitment after 
transplant, our findings do not exclude the possibility that DAMPs, 
such as HMGB1, might be released during the ischemia/reperfu-
sion phase and also trigger TLR activation (50, 51). Finally, the 
lung microbiome did not reveal significant differences between 
the pathogenic and nonpathogenic bacteria, making it less likely 
to account for PGD outcomes. Furthermore, these organisms 
would likely be cleared by the broad-spectrum antibiotics that 
are administered routinely to the donor before transplant and the 
recipient after transplant.
In conclusion, we show that contamination of donor lungs 
with levels of LPS insufficient to induce detectable injury before 
transplantation induces TLR4/MyD88 signaling in ischemia/
reperfusion-primed TRAMs to release CXCL2, leading to neutro-
phil recruitment. This priming of donor TRAMs is independent of 
the requirement for NCMs to recruit neutrophils to lung allografts 
from naive donors after lung transplantation. Our results highlight 
the potential utility of strategies targeting CXCL2, scavenging 
ROS, or blocking TLR4 or coreceptor CD14 on donor TRAMs and 




Transplant patients. Bronchoscopic bronchoalveolar lavage and lung 
biopsies were used to collect donor TRAMs at the different time points 
outlined in the experiments.
P. aeruginosa–infected patients. Small aliquots (1–4 mL) of nonbron-
choscopic bronchoalveolar lavage (NBBAL) fluid were collected from 
patients with suspected infection (16).
BALF processing. Fluid was filtered through a 40-μm nylon cell 
strainer and following staining, cells were sorted at the Northwest-
ern University Robert H. Lurie Comprehensive Cancer Center Flow 
Cytometry Core facility using FACSARIA III (BD Bioscience). TRAMs 
were identified using sequential gating as singlets/CD45+/live/CD15–/ 
CD206++/CD169+/HLA-DR+/high autofluorescence+ as previously 
described (16).
Mice and procedures
WT C57BL/6J (B6), B6.FVB-Tg(ITGAMDTR/EGFP)-34Lan/J 
(CD11b-DTR), and Rag–/– IL2g–/– mice with transgenes for human 
GM-CSF and IL-3 (MISTRG mice) (16), Cxcr2–/–, and Nr4a1–/– mice 
were obtained from the Jackson Laboratory. Tlr4–/– and Cd11cCre 
Myd88Δ mice in B6 background were a gift from Harris Perlman 
(Department of Medicine, Northwestern University, Chicago) and 
B6 lysozyme M (LysM)–GFP mice were originally obtained from 
lung transplantation. While removing LPS from donor lungs is 
unlikely to be feasible, treatment of donor lungs with a history 
of pneumonia with these inhibitors before transplantation might 
safely reduce the risk of PGD and expand the pool of lungs avail-
able for transplantation. Importantly, we were able to confirm 
key aspects of our murine model in homologous cell populations 
isolated from patients with severe pneumonia in our intensive 
care unit and in patients undergoing lung transplantation in our 
center. More careful phenotyping of the exposure history in the 
donor lung might reveal additional environmental exposures that 
drive PGD. Putative exposures can be causally examined in pre-
clinical murine lung transplant models as we show in this study. 
While our data using bone marrow chimeric mice combined with 
scRNA-Seq data implicated TRAMs as the predominant cell type 
necessary for the production of CXCL2, a role for another cell type 
in the donor lung releasing CXCL2 should be recognized since it 
has been shown that alveolar epithelial cells can produce CXCL2 
in response to pathogens (49). Additionally, while the focus of 
our study was on neutrophil recruitment that was dependent on 
CXCL2, it should be emphasized that other cytokines and chemo-
kines would be necessary for the propagation of downstream 
inflammatory cascade and need to be further elucidated.
Fulminant bacterial infections or high levels of endotoxin 
will likely lead to severe injury to the donor lungs, making them 
unsuitable for clinical transplantation. Our rationale for using low 
levels of endotoxin was to specifically test the hypothesis that 
residual PAMPs, which persist after treatment of donor pneu-
monias and are insufficient to cause injury in the native lungs, 
can drive the pathogenesis of PGD. We recognize that damage- 
associated molecular patterns (DAMPs), such as HMGB1, might 
be released during the ischemia/reperfusion phase and trigger 
TLR4 activation (50, 51). While we tested the role of endotoxin 
in this study, it is possible that these DAMPs may also contribute 
to the clinical heterogeneity observed in the incidence of PGD. 
Hence their role should be explored in future studies. Our current 
and previously published data suggest the development of PGD 
involves several cell populations including NCMs, neutrophils, 
alveolar macrophages, and CMs. The complex signaling path-
ways leading to their orchestrated sequential recruitment and 
activation are incompletely understood. Additionally, whether 
compartmental separation of these DAMPs and PAMPs can selec-
tively activate donor NCMs or TRAMs should also be explored. It 
is intriguing that NCMs play a role in neutrophil recruitment in 
response to DAMPs while recipient CMs permeabilize the pulmo-
nary endothelium to promote neutrophil extravasation (11–13, 15). 
In contrast, we found that donor TRAMs are capable of driving 
both neutrophil recruitment as well as neutrophil extravasation 
since depletion of TRAMs resulted in a marked decrease in both. 
Whether TRAMs mediate neutrophil extravasation through the 
recruitment of recipient classical monocytes remains unknown. 
Future studies might examine the role of TRAMs in monocyte 
trafficking to the lung allografts as they might introduce common 
therapeutic targets to ameliorate both ischemia/reperfusion and 
endotoxin-associated lung allograft injury.
Our study suggests several avenues for future investigation. 
While the data using bone marrow chimeric mice combined with 
scRNA-Seq data implicated TRAMs as the predominant cell type 
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the graft was stored at 4°C for a period of 90–120 minutes of cold- 
ischemic time before implantation. The recipient mouse received 
subcutaneous buprenorphine (0.1 mg/kg) 30 minutes before the tho-
racic surgical incision and every 6 hours as needed after the trans-
plant procedure. The recipient mouse was intubated and a left-sided 
thoracotomy was performed within the third intercostal space. The 
recipient’s native lung was gently clamped and pulled out of the tho-
racic cavity. The space between the artery, the vein, and the bron-
chus was dissected separately. The artery and vein were temporarily 
occluded using 8-0 nylon ligatures. The anastomoses were completed 
by fixating each cuff with 10-0 nylon ligatures. The 8-0 ligatures were 
released (first vein, then artery) and the lung inflated. The chest inci-
sion was closed and recipients separated from the ventilator when 
spontaneous respiration resumed. No antibiotics or immunosuppres-
sive agents were used postoperatively in any groups. For LPS-treated 
donors with or without TLR4 or CD14 antagonist, we treated donor 
mice 30 minutes before procurement with 0.5 μg/g/BW i.t. LPS with 
or without 100 μg/ms/i.v., respectively.
Adoptive transfer of TRAMs. A tracheostomy was performed in the 
donor mice to harvest TRAMs from BALF. Briefly, BALF was obtained 
with 2 mM EDTA solution in PBS lavage following by centrifugation 
and red blood cell (RBC) lysis. TRAMs obtained from BAL were resus-
pended in the final volume for adoptive transfer to the recipient mice 
5 × 105 per recipient.
TRAM and monocyte depletion. Clodronate-loaded liposomes 
and control phosphate-buffered saline liposomes were purchased 
from Clodronateliposomes.com. At specific time points, mice were 
injected i.t. (50 μL) or i.v. (200 μL) with clodronate-loaded lipo-
somes or control PBS-loaded liposomes to deplete macrophages 
or Ly6Chi monocytes, respectively (54). Cytotoxic anti-CCR2 anti-
bodies were a gift of Steffen Jung (Weizmann Institute of Science, 
Rehovot, Israel) and used for selective depletion of CCR2+ classical 
monocytes as previously described. Diphtheria toxin (List Biologic 
Laboratories, Inc.) was dissolved in 100 μL PBS and administered 
i.p. to CD11b-DTR mice 24 hours before LPS administration to sys-
tematically deplete CD11b-expressing cells.
Compartmental lung intravenous staining for neutrophils 
extravasation
Intravenous and intratracheal procedures were performed using 
an adaptation of previously described methods (34). Briefly, 6 μg 
APC-conjugated anti-CD45 in 100 μL sterile PBS was injected i.v. and 
allowed to circulate for 3 minutes before euthanasia with an overdose 
of Euthasol (Virbac). Tracheostomy was performed. The vena cava was 
transected and the right ventricle flushed with 10 mL HBSS to wash 
unbound i.v. antibody.
Multicolor flow cytometry
Single-cell suspensions from the whole lung of the mouse were 
obtained and murine lung cell staining performed as previously 
described (32, 55). Table 1 shows all antibodies used. Fixed samples 
were run on a custom LSRFortessa Cell Analyzer (BD Bioscience) 
or BD FACS Symphony A5-Laser Analyzer for flow cytometry anal-
ysis at the Northwestern University Robert H. Lurie Comprehen-
sive Cancer Center Flow Cytometry Core facility. Acquired data 
were analyzed with FlowJo v10.6 (FlowJo). For TRAM sorting, lung 
airways were lavaged 5 times with 0.5 mL PBS. BALF was cen-
Klaus Ley (La Jolla Institute for Immunology). All mice were main-
tained in a specific pathogen–free facility at the Center for Com-
parative Medicine at Northwestern University and used for the 
described experiments at the age of 9 to 14 weeks and between 24 
and 28 g body weight.
LPS induced lung injury. LPS from E. coli (serotype O111:B4; Mil-
liporeSigma), P. aeruginosa 10 (serotype 10.22; MilliporeSigma), and 
Klebsiella pneumoniae (source strain ATCC 15380; MilliporeSigma) 
were used at 2 μg/g BW (body weight) or 0.5 μg/g BW (E. coli) and 
0.2 μg/g BW P. aeruginosa and K. pneumoniae diluted in 50 μL PBS 
and instilled i.t. MISTRG mice reconstitution and mouse pneumonia 
model were previously described (16).
Broncho alveolar lavage fluid. BALF was obtained by instilling 
lung airways 5 times with 0.5 mL PBS. BALF was centrifuged and the 
supernatant was used for chemokine and cytokine determination as 
described below.
Purified anti-CXCL2 (clone 40605; R&D Systems) or rat IgG2B 
isotype control (R&D Systems), TAK-242, TLR4 antagonist (AbMole), 
IAXO-101, CD14/TLR4 antagonist (Innaxon), NAC (Millipore- 
Sigma), MT (MilliporeSigma), and DM (MilliporeSigma) were com-
mercially acquired. Anti-CXCL2 antibodies or isotype control (200 
μg/ms, i.v.), TAK-242 (1 μg/g BW, i.v.), and IAXO-101 (3 μg/g BW, i.t.) 
were administrated to the donors 30 minutes before i.t. LPS (52, 53). 
For ROS scavenger experiments, donor mice were treated with the 
first dose of the NAC (100 mg/kg BW, i.v.), MT (5 mg/kg/ms, i.p.), or 
DM (10 mg/kg BW, i.v.) 1 hour before transplant; then, recipient mice 
received same doses of ROS scavenger 5 minutes before reperfusion 1 
hour (NAC) or 2 hours (TM and DM) after reperfusion.
Mouse lung transplant with and without LPS. Orthotopic murine 
left lung transplantation was performed as previously described (13). 
Briefly, a donor mouse was anesthetized with a mixture of xylazine 
(10 mg/ kg) and ketamine (100 mg/kg). Donor lungs were flushed 
through the pulmonary artery with 3 mL saline solution and the heart-
lung block was excised and kept in cooled (4°C) preservative solu-
tion. The bronchus, pulmonary vein, and artery were dissected and 
prepared for anastomosis. A customized cuff made of a Teflon intra-
venous catheter was applied to the vascular structures and fixated 
with a 10-0 nylon ligature. After placement of a microvessel clip on 
the bronchus to avoid airway infiltration with preservative solution, 
Table 1. Antibodies used for flow cytometry and sorting
Antigen Clone Fluorochrome Manufacturer 
CD24 M1/69 BUV395/APC BD Horizon 
CD45 30-F11 FITC/APC BioLegend
CD11b M1/70 FITC/APCCy7 BD Horizon/BioLegend 
I-A/I-E M5/114.15.2 FITC/PercpCy5.5 BioLegend
Ly6C HK 1.4 eFluor450 eBioscience
Ly6G 1A8 AlexaFluor 700 BioLegend
NK1.1 PK136 AlexaFluor 700 BD Biosciences
CD64 X54-5/7.1 PE BioLegend
SiglecF E50-2440 PECF594 BD Biosciences
CD11c HL3 PECy7 BD Biosciences
TLR4 MT5510 PECy7 BioLegend
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attach the lung tissue to the bottom of the cover glass without direct 
pressure on the exposed lung. For time-lapse imaging of leukocyte 
migration in the tissue parenchyma, we averaged 15 video-rate 
frames (0.5 s/slice) during the acquisition to match the ventilator 
rate and minimize movement artifacts. Each plane represents an 
image of 220 × 240 μm in the x and y dimensions. To visualize blood 
vessels, 20 μL of 655-nm nontargeted Quantum dots (Q-dots) in 100 
μL PBS was injected i.v. before imaging. Two-photon excitation pro-
duces a second harmonic signal from collagen (56) around alveoli, 
thus providing a useful landmark for the air spaces. Explanted tissue 
was examined as described (56–58).
mRNA isolation and qPCR
Total RNA was extracted using miRNeasy Mini Kit (Qiagen). cDNA 
was synthesized from 1 μg total RNA by using a qScript cDNA Synthe-
sis kit (Quanta Biosciences) and mRNA expression was determined 
by qPCR using iTaq Universal Probes Supermix (Bio-Rad). Relative 
expression of the transcripts was determined according to the ΔΔCt 
method using actin or RPL19 as reference for normalization. Primers 
used were as follows: cxcl2-F, CCCAGACAGAAGTCATAGCCAC; 
cxcl2-R, GCCTTGCCTTTGTTCAGTATC; tlr4-F, TGGCTGGTTTA-
CACATCCATCGGT; tlr4-R, TGGCACCATTGAAGCTGAGGTCTA; 
B-actin-F, CACCACACCTTCTACAATGA; B-actin-R, GTCTCAAA-
CATGATCTGGGT.
Reactive oxygen species measurement
The ROS levels were examined in lung samples using a commercially 
available assay (In Vitro OxiSelect Assay Kit, Cell Biolabs). Brief-
ly, we homogenized the lung tissue obtained at the different time 
points during the lung transplantation (native donor lung before 
reperfusion, cold ischemia, warm ischemia, 30 minutes after reper-
fusion) according to the manufacturer’s recommendation and 
resuspended it in the assay buffer. The cell-permeable fluorogenic 
probe was then used to assess the ROS levels. Fluorescence was read 
on a Spectramax plate reader.
Immunocytochemistry and fluorescence microscopy
We used cytospin to immobilize 10,000–50,000 TRAMs onto slides, 
where cells were fixed with 4% formaldehyde, permeabilized with 
0.5% Triton X-100, and immunostained with anti–PE-TLR4 anti-
body (BioLegend, clone HTA125). Nuclei were stained with Hoechst 
33342 (MilliporeSigma). For immunocytochemistry, cells were 
imaged using a Zeiss Axioplan 2 fluorescence microscope. Confocal 
images were acquired using a Zeiss Axio Imager Z2 with ApoTome.2 
microscope equipped with Axiocam 503 Mono, X-Cite 120 LED 
Boost System, and Zen 2.3 software (Carl Zeiss).
Microbiome analysis
Ten BAL washings of donor lungs were obtained in the operating 
room at the time of organ implantation. Rectal swabs were obtained 
for 5 of these patients at the same time. Samples were immediately 
centrifuged to collect cellular DNA and stored at –80° C. Samples then 
underwent batched genomic DNA extraction, PCR amplification tar-
geting the 16S ribosomal RNA gene, pooling, and high-throughput 
sequencing with paired-end, 300-base reads on the Illumina MiSeq 
platform to obtain overall taxonomic compositions of the microbial 
communities. A sterile swab obtained just before DNA extraction 
trifuged and the cell pellet was processed and prepared for flow 
sorting using a FACSARIA 4-Laser Sorter at the Northwestern 
University Robert H. Lurie Comprehensive Cancer Center Flow 
Cytometry Core facility.
Wet/dry ratio
Weight ratio for pulmonary edema was measured by harvesting lungs 
after reperfusion at defined experiments, weighed, and then placed at 
54°C until a stable dry weight was achieved. The ratio of wet weight to 
dry weight was calculated as an indicator of pulmonary edema.
Histology and H&E staining
For histological analyses, the whole lung was harvested and gently 
flushed through the pulmonary artery with 3 mL saline. Parafor-
maldehyde (4%) was instilled into the trachea with a pressure of 10 
cmH2O then fixed for 48 to 72 hours before being embedded in par-
affin. The whole lung was serially sectioned and stained with H&E. 
Pictures were acquired using a Nikon TE-2000-U microscope.
ELISA
Endotoxin (Thermo Fisher Scientific), CXCL1, CXCL2, CXCL10, 
and TNF-α ELISA was performed using a commercially available kit 
accordingly to the manufacturer’s instructions (R&D Systems).
Secondary transcriptomic analysis
RNA-sequencing. RNA isolation and sequencing procedures are 
detailed in our previous manuscript (34). For all analyses, normalized 
tables of counts were generated from raw counts using the EdgR pack-
age (version 3.18.1). Filtering for low counts was performed by exclud-
ing genes that have the expression from more than half of all the sam-
ples. Functional enrichment analysis with GO biological processes 
was performed with GOrilla with the top 1000 genes upregulated in P. 
aeruginosa positive samples for all clusters. Significantly upregulated 
genes were used to identify the top biological processes (–log10 [P 
value]). Heatmaps of pathway genes based on the top GO processes 
were identified and hierarchical clustering was generated to show the 
expression of these genes in naive, low, and high virulence samples for 
MISTRG mice (16).
Reanalysis of single-cell RNA-Seq data sets. To assess expression pat-
tern of TRL4 in human lung, we queried 3 recently published single- 
cell RNA-Seq data sets (29, 30, 31). Data and author’s annotations 
were accessed from GSE122960 (29), tissuestabilitycellatlas.org (30), 
and GSE135893 (31). Only nondiseased lungs (indicated as donor or 
control) were used for analysis. Precomputed R objects were loaded 
into Seurat 3.1.4 and expression of TLR4 was visualized using 
FeaturePlot command.
Two-photon microscopy
A custom-built 2-photon microscope running ImageWarp acquisi-
tion software (A&B Software) was used for time-lapse imaging. Mice 
were anesthetized with an i.p. injection of ketamine (50 mg/kg) and 
xylazine (10 mg/kg) and maintained with administration of half 
doses every hour through the imaging process. Mice were intubated 
orotracheally and ventilated with room air at a rate of 120 breaths/
min and with a tidal volume of 0.5 mL. Left thoracotomy was per-
formed to expose the left lung, and the lung was imaged using a cus-
tom-built chamber maintained at 37°C. VetBond ring was used to 
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
4 4 6 8 jci.org   Volume 130   Number 8   August 2020
Board (STU00106589 and STU00201397). All study subjects pro-
vided informed written consent.
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